Skip to main content
Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study.
- Author(s): Arshad, Aysha
- Johnson, Christopher K
- Mittal, Suneet
- Buch, Eric
- Hamam, Ismail
- Tran, Thanh
- Shaw, Richard E
- Musat, Dan
- Preminger, Mark
- Sichrovsky, Tina
- Herweg, Bengt
- Shivkumar, Kalyanam
- Hummel, John
- Steinberg, Jonathan S
- et al.
Published Web Locationhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Comparative+safety+of+periablation+anticoagulation+strategies+for+atrial+fibrillation:+Data+from+a+large+multicenter+study
No data is associated with this publication.
BackgroundThere are a variety of periprocedural anticoagulation strategies for atrial fibrillation (AF) ablation, including the use of dabigatran. It is unclear which strategy is superior.
ObjectiveTo compare the safety and efficacy of anticoagulation with uninterrupted warfarin, dabigatran, and warfarin with heparin bridging in patients undergoing ablation of AF at four experienced centers.
Methods and resultsIn this retrospective analysis, 882 patients (mean age: 61 ± 11 years) underwent ablation of AF using uninterrupted warfarin (n = 276), dabigatran (n = 374), or warfarin with heparin bridging (n = 232) for periprocedural anticoagulation. The rate of total complications was 23/276 (8.3%) in the uninterrupted warfarin group, 30/374 (8.0%) in the dabigatran group, and 29/232 (12.5%) in the bridged group (P = 0.15). Major complications were more frequent in the uninterrupted warfarin group 12/276 (4.3%) compared with 3/374 (0.8%) in dabigatran and 6/232 (2.6%) in the bridged group (P = 0.01). The most common major complication was the need for transfusion or occurrence of major bleeding. Minor complications did not differ among the three groups. On multivariate analysis, female gender (odds ratio [OR] 1.93, confidence interval [CI] 1.16-3.19, P = 0.011), bridging heparin (OR 2.13, CI 1.100-3.941, P = 0.016), use of triple antithrombotic therapy (OR 1.77, CI 1.05-2.98, P = 0.033), and prior myocardial infarction (OR 2.40, CI 1.01-5.67, P = 0.046) independently predicted total complications.
ConclusionsWhen comparing the use of uninterrupted warfarin, dabigatran, and warfarin with heparin bridging in patients undergoing catheter ablation of AF, dabigatran was not associated with increased risk, major complications were more common in the uninterrupted warfarin group, and after adjustment, warfarin with bridging increased total complications.
Item not freely available? Link broken?Report a problem accessing this item